600223.SH
福瑞达
SSE · Healthcare · Real Estate - Development · CN
CNY 5.55
+1.28%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.7B | 3.7B | 4.0B | 4.6B | 13.0B |
| Cost of Revenue | 1.7B | 1.7B | 1.9B | 2.5B | 9.8B |
| Gross Profit | 2.0B | 1.9B | 2.1B | 2.1B | 3.2B |
| Operating Expenses | |||||
| R&D Expense | 156.8M | 161.7M | 166.8M | 153.4M | 133.9M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 180.2M | 179.4M | 183.0M | 223.0M | 350.0M |
| Selling & Marketing Expense | 1.4B | 1.4B | 1.5B | 1.4B | 1.3B |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 1.8B | 1.7B | 1.8B | 1.9B | 2.7B |
| Cost and Expenses | 3.5B | 3.4B | 3.7B | 4.4B | 12.4B |
| Operating Income (EBIT) | 258.6M | 286.1M | 337.8M | 419.4M | 310.8M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 259.3M | 284.9M | 346.3M | 413.0M | 261.1M |
| Income Tax Expense | 47.4M | 47.4M | 49.9M | 46.8M | 196.0M |
| Bottom Line | |||||
| Net Income | 168.9M | 187.8M | 243.5M | 303.4M | 45.5M |
| Earnings from Cont. Ops | 212.0M | 237.5M | 296.4M | 252.6M | 65.1M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 168.9M | 187.8M | 243.5M | 303.4M | 45.5M |
| Per Share | |||||
| Basic EPS | CN¥0.17 | CN¥0.18 | CN¥0.24 | CN¥0.30 | CN¥0.04 |
| Diluted EPS | CN¥0.17 | CN¥0.18 | CN¥0.24 | CN¥0.30 | CN¥0.04 |
| Revenue Per Share | CN¥3.46 | CN¥3.50 | CN¥3.92 | CN¥4.53 | CN¥11.40 |
| Shares | |||||
| Basic Shares Outstanding | 1.1B | 1.0B | 1.0B | 1.0B | 1.1B |
| Diluted Shares Outstanding | 1.1B | 1.0B | 1.0B | 1.0B | 1.1B |
| Profitability Metrics | |||||
| EBITDA | — | 403.0M | 445.3M | 565.3M | 435.3M |
| D&A | — | 116.9M | 107.5M | 145.8M | 124.5M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026